As part of NOMA's continued commitment to you, I would like to report on recent meetings that I have had with the Governor's Staff regarding the implementation of AB474 or "the controlled substances bill." I attended a meeting on November 30th along with many other professional societies and practice groups to review samples of documentation forms that will be required after January 1, 2018 to prescribe controlled substances for pain. Specifically, we have repeatedly asked for clarification from the Pharmacy Board and have received a verbal answer at these meetings that INFORMED CONSENT, the CONTROLLED SUBSTANCE MEDICATION AGREEMENT and the RISK FOR ADDICTION ASSESSMENTS are STRICTLY FOR CONTROLLED SUBSTANCES FOR PAIN (i.e.: opiates). This is despite the law in its final form being somewhat unclear on this.
Currently no one (i.e.: licensing boards or State) will put out a written clarification on this matter. I intend to push harder for this, and I will keep you informed.
Otherwise we were able to agree on format and language on the prescriptions but still have issues to iron out on sample forms for the other documentation. especially the informed consent. Again I will keep you posted.
You can click these links to find a
, the Pharmacy Board's One Page "
" and the Nursing Board's extensive
to approaching these patients on our website. We are also working on our own concise and easy to understand flow sheets.
Again NOMA will be monitoring and trying to help alleviate fears regarding the new law's impending implementation.
Bruce Fong, DO